Private Advisor Group LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL) by 38.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,849 shares of the company’s stock after buying an additional 11,378 shares during the quarter. Private Advisor Group LLC’s holdings in Colgate-Palmolive were worth $2,735,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in CL. CSat Investment Advisory L.P. acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at approximately $111,000. Bridgeworth LLC acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at approximately $120,000. Price Capital Management Inc. acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $121,000. Fort L.P. acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at approximately $123,000. Finally, O Brien Wealth Partners LLC acquired a new stake in Colgate-Palmolive in the third quarter worth $123,000. Institutional investors own 75.08% of the company’s stock.
In other news, insider Mukul Deoras sold 11,334 shares of the firm’s stock in a transaction on Monday, August 13th. The stock was sold at an average price of $65.10, for a total transaction of $737,843.40. Following the transaction, the insider now directly owns 32,625 shares of the company’s stock, valued at $2,123,887.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Henning I. Jakobsen sold 1,015 shares of the firm’s stock in a transaction on Tuesday, September 11th. The shares were sold at an average price of $67.05, for a total value of $68,055.75. Following the transaction, the chief financial officer now directly owns 36,193 shares in the company, valued at $2,426,740.65. The disclosure for this sale can be found here. Insiders have sold 149,811 shares of company stock worth $9,835,756 over the last three months. Corporate insiders own 1.02% of the company’s stock.
Several equities research analysts have weighed in on the company. Argus reaffirmed a “buy” rating and issued a $75.00 target price (up from $72.00) on shares of Colgate-Palmolive in a research report on Tuesday, September 18th. Zacks Investment Research raised Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Atlantic Securities assumed coverage on Colgate-Palmolive in a research report on Thursday, September 20th. They issued a “neutral” rating and a $71.00 target price on the stock. ValuEngine raised Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, July 31st. Finally, Wells Fargo & Co reaffirmed a “hold” rating and issued a $64.00 target price on shares of Colgate-Palmolive in a research report on Friday, July 27th. Four investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $68.06.
Shares of CL opened at $63.80 on Friday. The firm has a market cap of $53.19 billion, a PE ratio of 22.23, a price-to-earnings-growth ratio of 3.01 and a beta of 0.75. The company has a current ratio of 1.11, a quick ratio of 0.77 and a debt-to-equity ratio of 64.85. Colgate-Palmolive has a one year low of $57.41 and a one year high of $77.91.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 26th. The company reported $0.72 EPS for the quarter, meeting analysts’ consensus estimates of $0.72. The company had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. The company’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period last year, the company earned $0.73 earnings per share. Sell-side analysts anticipate that Colgate-Palmolive will post 2.96 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 15th. Stockholders of record on Friday, October 19th will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.63%. The ex-dividend date is Thursday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.54%.
TRADEMARK VIOLATION NOTICE: This report was first posted by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/11/10/colgate-palmolive-cl-shares-bought-by-private-advisor-group-llc.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Recommended Story: What is a Reverse Stock Split?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.